The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

CN Kotton, D Kumar, AM Caliendo, S Huprikar… - …, 2018 - journals.lww.com
Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …

[HTML][HTML] Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation

J Styczynski - Infectious diseases and therapy, 2018 - Springer
Cytomegalovirus (CMV) is an agent of global infection, and its acquisition in a population is
characterized by an age-dependent rise in seropositivity. After primary infection, CMV …

Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

RR Razonable, A Humar - Clinical transplantation, 2019 - Wiley Online Library
Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …

[HTML][HTML] Human cytomegalovirus and autoimmune diseases: where are we?

F Gugliesi, S Pasquero, G Griffante, S Scutera… - Viruses, 2021 - mdpi.com
Human cytomegalovirus (HCMV) is a ubiquitous double-stranded DNA virus belonging to
the β-subgroup of the herpesvirus family. After the initial infection, the virus establishes …

[HTML][HTML] Cytomegalovirus infection after liver transplantation

BC Lizaola-Mayo, EA Rodriguez - World Journal of Transplantation, 2020 - ncbi.nlm.nih.gov
Human cytomegalovirus (CMV) represents the most common opportunistic infection in liver
transplant recipients. CMV infections in post liver transplant patients cause significant …

Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting

Z Hakimi, S Aballéa, S Ferchichi… - Transplant Infectious …, 2017 - Wiley Online Library
Background We investigated the impact of early‐(E‐CMV) and late onset (L‐CMV)
cytomegalovirus disease on the probability of graft rejection, graft failure, mortality, and …

[HTML][HTML] Infectious complications following small bowel transplantation

JT Silva, R San-Juan, B Fernández-Caamaño… - American Journal of …, 2016 - Elsevier
Microbiological spectrum and outcome of infectious complications following small bowel
transplantation (SBT) have not been thoroughly characterized. We performed a retrospective …

Prevention and treatment of cytomegalovirus infections in solid organ transplant recipients

CE Koval - Infectious Disease Clinics, 2018 - id.theclinics.com
Human cytomegalovirus (CMV) is a double-stranded DNA virus and member of the herpes
virus family. Infection prevalence reaches 60% to 80% by adulthood in the United States and …

[HTML][HTML] Living donor intestinal transplantation: recipient outcomes

G Wu, C Liu, X Zhou, L Zhao, W Zhang, M Wang… - Annals of …, 2022 - journals.lww.com
Objective: To examine outcomes of living-donor intestinal transplant (LDITx) recipients.
Background: LDITx is not routinely performed because of surgical risks to the donor and the …

[HTML][HTML] Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?

E García-Ríos, M Nuévalos, FJ Mancebo… - Frontiers in …, 2021 - frontiersin.org
During the last decade, many studies have demonstrated the role of CMV specific T-cell
immune response on controlling CMV replication and dissemination. In fact, it is well …